LiliumX

www.liliumx.com

LiliumX are a recent University of Oxford spinout that drives innovation in bispecific antibody R&D against cancer. We believe that current bispecific antibody R&D is outdated and focused only on limited known biology. We break free of this limitation by using our highly modular high-throughput protein platform to discover novel target combinations to make first-in-class bispecific antibodies with entirely new mechanisms of action. We are backed by mission-driven investors including Y Combinator, Hoxton Ventures, Magnet Ventures, and Acequia Capital. We are disrupting the field of bispecific antibodies and we welcome you to join us in this revolution.

Read more

Reach decision makers at LiliumX

Lusha Magic

Free credit every month!

LiliumX are a recent University of Oxford spinout that drives innovation in bispecific antibody R&D against cancer. We believe that current bispecific antibody R&D is outdated and focused only on limited known biology. We break free of this limitation by using our highly modular high-throughput protein platform to discover novel target combinations to make first-in-class bispecific antibodies with entirely new mechanisms of action. We are backed by mission-driven investors including Y Combinator, Hoxton Ventures, Magnet Ventures, and Acequia Capital. We are disrupting the field of bispecific antibodies and we welcome you to join us in this revolution.

Read more
icon

City (Headquarters)

London

icon

Employees

1-10

icon

Founded

2021

icon

Social

  • icon
  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Advisor

    Email ****** @****.com
    Phone (***) ****-****
  • Board Observer

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(12)

Reach decision makers at LiliumX

Free credits every month!

My account

Sign up now to uncover all the contact details